Register
Journal Updates
eMediNexus Coverage from: 
ADA public policy statement on insulin access and affordability
eMediNexus,  25 May 2018
remove_red_eye 716 Views
#Diabetes and Endocrinology #Internal Medicine

0 Read Comments                

In a new public policy statement on insulin access and affordability released on May 24, 2018, the American Diabetes Association (ADA) recommends increasing transparency across the entire insulin supply chain; streamlining the approval process for biosimilar insulins, lowering or removing patient cost-sharing for insulin and increasing access to health care coverage for all people with diabetes.
To continue reading this article
Sign in with Medtalks

Continue reading your article with a eMediNexus account.
Free Membership!